Concepedia

Jonathan Corren

JC

Statistics

Publications

106

Citations

16.6K

H-Index

52

Active since

1991

Affiliations

University of California, Los Angeles(Current)

Regeneron (United States)

Sanofi (United States)

AstraZeneca (United States)

University of Colorado Denver

Jonathan Corren is an author at University of California, Los Angeles specializing in pharmacotherapy, asthma pharmacotherapy, and pharmacology.

ORCID

Publications per year

1991–2025

106

Publications

106

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

Mario Castro, Jonathan Corren, Ian Pavord et al. · New England Journal of Medicine · 2018 · 1.9K citations · Full text

, , +13

Lebrikizumab Treatment in Adults with Asthma

Jonathan Corren, Robert F. Lemanske, Nicola A. Hanania et al. · New England Journal of Medicine · 2011 · 1.5K citations

, , +12

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

William W. Busse, Jonathan Corren, Bobby Q. Lanier et al. · Journal of Allergy and Clinical Immunology · 2001 · 1.3K citations · Full text

, , +16

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

Andrew Menzies‐Gow, Jonathan Corren, Arnaud Bourdin et al. · New England Journal of Medicine · 2021 · 967 citations · Full text

, , +6

Tezepelumab in Adults with Uncontrolled Asthma

Jonathan Corren, Jane R. Parnes, May Mo et al. · New England Journal of Medicine · 2017 · 938 citations · Full text

, , +16

1–5 of 106